BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26629895)

  • 1. An update on the current pharmacotherapy for endometrial cancer.
    de Haydu C; Black JD; Schwab CL; English DP; Santin AD
    Expert Opin Pharmacother; 2016; 17(4):489-99. PubMed ID: 26629895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapy for the treatment of endometrial cancer.
    Neri M; Peiretti M; Melis GB; Piras B; Vallerino V; Paoletti AM; Madeddu C; Scartozzi M; Mais V
    Expert Opin Pharmacother; 2019 Nov; 20(16):2019-2032. PubMed ID: 31451034
    [No Abstract]   [Full Text] [Related]  

  • 3. Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.
    Lheureux S; Oza AM
    Eur J Cancer; 2016 May; 59():99-108. PubMed ID: 27017291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management Strategies for Recurrent Endometrial Cancer.
    Connor EV; Rose PG
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):873-885. PubMed ID: 29972650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of endometrial cancer.
    Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
    Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new in systemic therapy for endometrial cancer.
    Kieser K; Oza AM
    Curr Opin Oncol; 2005 Sep; 17(5):500-4. PubMed ID: 16093803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the pharmacotherapy for endometrial cancer.
    Amadio G; Masciullo V; Stefano L; Scambia G
    Expert Opin Pharmacother; 2013 Dec; 14(18):2501-9. PubMed ID: 24138224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the chemotherapeutic management of endometrial cancer.
    Bregar A; Robison K; Dizon DS
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):659-65. PubMed ID: 25658891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in systemic therapy for advanced endometrial cancer.
    Tsoref D; Oza AM
    Curr Opin Oncol; 2011 Sep; 23(5):494-500. PubMed ID: 21673575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for endometrial cancer.
    Amadio G; Masciullo V; Ferrandina MG; Scambia G
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):497-509. PubMed ID: 25330855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapy as a future strategy in endometrial cancer.
    Thanapprapasr D; Thanapprapasr K
    Asian Pac J Cancer Prev; 2013; 14(6):3419-23. PubMed ID: 23886121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
    Papa A; Zaccarelli E; Caruso D; Vici P; Benedetti Panici P; Tomao F
    Expert Opin Investig Drugs; 2016; 25(1):31-49. PubMed ID: 26560489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment of metastatic endometrial cancer.
    Temkin SM; Fleming G
    Cancer Control; 2009 Jan; 16(1):38-45. PubMed ID: 19078928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Cancer: Obesity, Genetics, and Targeted Agents.
    McDonald ME; Bender DP
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):89-105. PubMed ID: 30683268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial carcinoma tumorigenesis and pharmacotherapy research.
    Shu J; Fang S; Teichman PG; Xing L; Huang H
    Minerva Endocrinol; 2012 Jun; 37(2):117-32. PubMed ID: 22691886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab in endometrial cancer treatment.
    Morotti M; Valenzano Menada M; Venturini PL; Ferrero S
    Expert Opin Biol Ther; 2012 May; 12(5):649-58. PubMed ID: 22428875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic therapy for advanced endometrial cancer].
    Pautier P; Pommeret F
    Bull Cancer; 2017 Dec; 104(12):1046-1053. PubMed ID: 29157555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized therapy in endometrial cancer: challenges and opportunities.
    Westin SN; Broaddus RR
    Cancer Biol Ther; 2012 Jan; 13(1):1-13. PubMed ID: 22198566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial cancer: Molecular markers and management of advanced stage disease.
    Arend RC; Jones BA; Martinez A; Goodfellow P
    Gynecol Oncol; 2018 Sep; 150(3):569-580. PubMed ID: 29843906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to chemotherapy and hormone therapy in endometrial cancer.
    Chaudhry P; Asselin E
    Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.